Wednesday, May 14, 2025 11:01:34 AM
Yesterday’s news…
GARDEN CITY, NY, May 13, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH), (the “Company” or “ProPhase”) a next generation biotech, genomics and consumer products company, announced today that they will be presenting first quarter 2025 financial results on a virtual conference call hosted by Renmark Financial on May 20, 2025, at 10:00 am EDT. Ted Karkus, CEO, looks forward to providing shareholders with an update on several positive activities, including the initiative to sell the Company’s wholly owned subsidiary, Nebula Genomics, and the Crown Medical Collections initiative to collect tens of millions of dollars in accounts receivable.
A press release detailing these results will be issued prior to the virtual conference call. ProPhase Labs Inc. welcomes stakeholders, investors, and other individual followers to register and attend this live event.
Investors interested in participating in this live event will need to register using the link below. After the event, a replay will be available on The Company’s investor website.
Complete release: https://www.globenewswire.com/news-release/2025/05/13/3080082/0/en/prophase-labs-inc-to-present-first-quarter-2025-financial-results-on-may-20-2025.html
GARDEN CITY, NY, May 13, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH), (the “Company” or “ProPhase”) a next generation biotech, genomics and consumer products company, announced today that they will be presenting first quarter 2025 financial results on a virtual conference call hosted by Renmark Financial on May 20, 2025, at 10:00 am EDT. Ted Karkus, CEO, looks forward to providing shareholders with an update on several positive activities, including the initiative to sell the Company’s wholly owned subsidiary, Nebula Genomics, and the Crown Medical Collections initiative to collect tens of millions of dollars in accounts receivable.
A press release detailing these results will be issued prior to the virtual conference call. ProPhase Labs Inc. welcomes stakeholders, investors, and other individual followers to register and attend this live event.
Investors interested in participating in this live event will need to register using the link below. After the event, a replay will be available on The Company’s investor website.
Complete release: https://www.globenewswire.com/news-release/2025/05/13/3080082/0/en/prophase-labs-inc-to-present-first-quarter-2025-financial-results-on-may-20-2025.html
PROTECT YOUR ASS-ets!!
Recent PRPH News
- ProPhase Labs Reports Year-End 2025 Results, Highlights Accelerating Settlement Activity and Investment-Ready Crown Medical Collections Platform • GlobeNewswire Inc. • 04/15/2026 01:05:00 PM
- ProPhase Labs Provides Business Update Highlighting Advancing Crown Medical Collections Activity • GlobeNewswire Inc. • 03/17/2026 12:00:00 PM
- ProPhase Labs Initiates Potential Sale or Strategic Partnership of BE-Smart™ and Advances Crown Medical Collections Initiative • GlobeNewswire Inc. • 02/03/2026 12:00:00 PM
- Join ProPhase Labs’ Exclusive Live Investor Webinar and Q&A Session on February 3rd • GlobeNewswire Inc. • 02/02/2026 01:00:00 PM
- ProPhase Labs Provides Crown Medical Collections Update; 250+ Insurance Payors Engaged, Approximately 50 Matters in Advanced Settlement Posture • GlobeNewswire Inc. • 01/26/2026 12:00:00 PM
- ProPhase Labs Uplists from Pink Sheets to OTC Market • GlobeNewswire Inc. • 01/22/2026 12:00:00 PM
- ProPhase Labs Provides Update on Convertible Debt Conversions, Capital Structure, and Underlying Asset Value • GlobeNewswire Inc. • 01/05/2026 10:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:10:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 12/29/2025 10:04:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/19/2025 08:37:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/19/2025 06:07:33 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 12/19/2025 06:03:21 PM
- ProPhase Labs Signs Non-Binding LOI for Proposed Reverse Merger with Advanced Biological Laboratories • GlobeNewswire Inc. • 12/19/2025 12:00:00 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 12/18/2025 06:30:45 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 12/12/2025 04:41:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/26/2025 07:15:29 PM
- Join ProPhase Labs’ Exclusive Live Investor Webinar and Q&A Session on December 1 • GlobeNewswire Inc. • 11/26/2025 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/25/2025 09:30:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/25/2025 09:30:50 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/19/2025 09:06:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/19/2025 02:00:52 PM
- ProPhase Labs Reported Results for the Third Quarter Ended September 30, 2025, and Will Hold a Virtual Conference Call Today at 2pm ET. • GlobeNewswire Inc. • 11/19/2025 01:13:06 PM
- ProPhase Labs, Inc. to Present Third Quarter 2025 Financial Results on November 19 • GlobeNewswire Inc. • 11/18/2025 01:00:00 PM
- ProPhase Labs Urges Shareholders to Vote by November 23 on Proxy Proposals • GlobeNewswire Inc. • 11/17/2025 01:00:00 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2025 09:15:04 PM
